Abstract Purpose of Review The purpose of this review is to examine the safety and
effectiveness of direct oral anticoagulants and provide recommendations for the treatment of …

Background: Studies indicate that women with atrial fibrillation (AF) are less likely to receive
anticoagulants despite their higher risk of stroke compared with men. Objective: To evaluate …

Background: The aim of the study was to evaluate the efficacy and safety of direct oral
anticoagulants (DOACs) in a subgroup of patients with atrial fibrillation (AF), CHADS2 …

Introduction: The real-world treatment of atrial fibrillation (AF) often involves the prescription
of new oral anticoagulants (NOACs) using dosing both lower and higher than recommended …

Background Several observational studies have shown that the inappropriate dosing use of
direct oral anticoagulants (DOACs) in atrial fibrillation (AF) that does not conform to …

Background: Sex-related difference in non-valvular atrial fibrillation (NVAF) patients treated
with direct oral anticoagulants (DOACs) is still to be investigated. We aimed to investigate …

The effectiveness and safety of direct oral anticoagulants (DOAC) compared with warfarin
remains uncertain in obese patients. We assessed the comparative effectiveness and safety …

Aims Worldwide observational studies are evidencing discordance between guidelines and
real‐world practice regarding direct oral anticoagulant drug (DOAC) doses. This systematic …

Introduction In the USA, there is a steady rise of atrial fibrillation due to the aging population
with increased morbidity. This study evaluated the risk of stroke/systemic embolism (S/SE) …

The presence of atrial fibrillation (AF), the most common sustained cardiac arrhythmia,
significantly increases the risk for stroke. Current guidelines recommend that the vitamin K …